Your browser doesn't support javascript.
loading
Restoring the epigenetic landscape of lung microbiome: potential therapeutic approach for chronic respiratory diseases.
KavianFar, Azadeh; Taherkhani, Hamidreza; Ahmadi, Ali; Salimi, Mahdieh; Lanjanian, Hossein; Masoudi-Nejad, Ali.
Affiliation
  • KavianFar A; Laboratory of Systems Biology and Bioinformatics (LBB), Department of Bioinformatics, Kish International Campus, University of Tehran, Kish Island, Iran.
  • Taherkhani H; Laboratory of Systems Biology and Bioinformatics (LBB), Department of Bioinformatics, Kish International Campus, University of Tehran, Kish Island, Iran.
  • Ahmadi A; Molecular Biology Research Center, Systems Biology and Poisonings Institute, Tehran, Iran. amasoudin@ut.ac.ir.
  • Salimi M; Department of Medical Genetics, Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
  • Lanjanian H; Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Masoudi-Nejad A; Laboratory of Systems Biology and Bioinformatics (LBB), Department of Bioinformatics, Kish International Campus, University of Tehran, Kish Island, Iran. amasoudin@ut.ac.ir.
BMC Pulm Med ; 24(1): 2, 2024 Jan 02.
Article in En | MEDLINE | ID: mdl-38166878
ABSTRACT

BACKGROUND:

Chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and bronchiectasis, present significant threats to global health. Recent studies have revealed the crucial role of the lung microbiome in the development of these diseases. Pathogens have evolved complex strategies to evade the immune response, with the manipulation of host cellular epigenetic mechanisms playing a pivotal role. There is existing evidence regarding the effects of Pseudomonas on epigenetic modifications and their association with pulmonary diseases. Therefore, this study aims to directly assess the connection between Pseudomonas abundance and chronic respiratory diseases. We hope that our findings will shed light on the molecular mechanisms behind lung pathogen infections.

METHODS:

We analyzed data from 366 participants, including individuals with COPD, acute exacerbations of COPD (AECOPD), bronchiectasis, and healthy individuals. Previous studies have given limited attention to the impact of Pseudomonas on these groups and their comparison with healthy individuals. Two independent datasets from different ethnic backgrounds were used for external validation. Each dataset separately analyzed bacteria at the genus level.

RESULTS:

The study reveals that Pseudomonas, a bacterium, was consistently found in high concentrations in all chronic lung disease datasets but it was present in very low abundance in the healthy datasets. This suggests that Pseudomonas may influence cellular mechanisms through epigenetics, contributing to the development and progression of chronic respiratory diseases.

CONCLUSIONS:

This study emphasizes the importance of understanding the relationship between the lung microbiome, epigenetics, and the onset of chronic pulmonary disease. Enhanced recognition of molecular mechanisms and the impact of the microbiome on cellular functions, along with a better understanding of these concepts, can lead to improved diagnosis and treatment.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiration Disorders / Bronchiectasis / Pulmonary Disease, Chronic Obstructive / Microbiota Limits: Humans Language: En Journal: BMC Pulm Med Year: 2024 Type: Article Affiliation country: Iran

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiration Disorders / Bronchiectasis / Pulmonary Disease, Chronic Obstructive / Microbiota Limits: Humans Language: En Journal: BMC Pulm Med Year: 2024 Type: Article Affiliation country: Iran